0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Grade Melatonin Products Market Research Report 2026
Published Date: 2026-01-30
|
Report Code: QYRE-Auto-23F18096
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Pharmaceutical Grade Melatonin Products Market Research Report 2024
BUY CHAPTERS

Global Pharmaceutical Grade Melatonin Products Market Research Report 2026

Code: QYRE-Auto-23F18096
Report
2026-01-30
Pages:151
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Grade Melatonin Products Market Size

The global Pharmaceutical Grade Melatonin Products market was valued at US$ 1192 million in 2025 and is anticipated to reach US$ 1865 million by 2032, at a CAGR of 6.7% from 2026 to 2032.

Pharmaceutical Grade Melatonin Products Market

Pharmaceutical Grade Melatonin Products Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Grade Melatonin Products competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Pharmaceutical Grade Melatonin Products production reached approximately 55.85 million units , with an average global market price of around US$ 20 per unit.
Pharmaceutical-grade melatonin products are prescription drugs or high-standard pharmaceutical preparations made from melatonin raw materials produced in accordance with pharmaceutical standards (such as USP, EP, BP, etc.) and GMP regulations. These include sustained-release tablets, immediate-release tablets, microcapsules, oral liquids, sprays, and hospital-prepared formulations, used to treat or assist in the treatment of insomnia, circadian rhythm disorders, sleep disorders in the elderly, and insomnia related to autism spectrum disorder (ASD) and neurogenetic diseases in some children. Representative products include Neurim/Aspen's sustained-release tablets Circadin and children's sustained-release tablets Slenyto, as well as various generic or branded melatonin preparations marketed by companies such as Aspen Pharmacare, AGB-Pharma, Alturix, Pharma Nord, Teva, and Mylan. Compared to ordinary food-grade or dietary supplements, pharmaceutical-grade products adhere to stricter drug regulatory requirements regarding raw material purity, impurity profile control, dissolution and sustained-release profiles, bioequivalence, stability testing, and evidence of clinical efficacy and safety. They are often dispensed as prescription drugs in hospitals, pharmacies, or after online consultations with doctors/pharmacies.
From an industry chain perspective, the upstream of pharmaceutical-grade melatonin products mainly consists of melatonin API and excipient suppliers that meet USP/EP/BP standards, including Swati Spentose, Biophore India, and Laurus Labs in India, and Huanggang Saikang (Nutrakey system) and Sichuan Benepure in China. These suppliers provide pharmaceutical-grade melatonin and excipients with a purity of 98–99.9% through pharmacopoeia standards, DMF/ASMF, EU-WC, and other systems. The midstream is handled by pharmaceutical companies specializing in neuroscience and sleep, such as Neurim Pharmaceuticals, AGB-Pharma, Alturix, Teva, and Mylan, which develop formulations and manufacture pharmaceutical products, forming extended-release tablets, pediatric formulations, and generic drugs for various countries. The downstream is provided to end patients through hospital prescriptions, community pharmacies, public health insurance catalogs, and compliant online consultation platforms for the treatment of chronic insomnia in the elderly, ASD/NGD-related insomnia in children, and jet lag syndrome. Some high-standard dietary supplement brands also use pharmaceutical-grade melatonin. APIs are sold to physicians and functional medicine clinics. Overall, the high degree of specialization and international certification requirements on the raw material side, the sustained-release technology and pediatric-specific dosage form development on the formulation side, and the regulatory and reimbursement policies of various countries downstream, together determine the positioning and profit model of pharmaceutical-grade melatonin products between "pharmaceuticals" and "high-end nutritional products".
The annual production capacity of a single-line Pharmaceutical Grade Melatonin Products is approximately 500k units, with a gross profit margin of approximately 55%-70%.
Overall, pharmaceutical grade melatonin products occupy a niche, higher-end position between conventional hypnotic drugs and over-the-counter melatonin supplements, combining physician-led, evidence-based use with growing public awareness of sleep health. Thanks to a more favourable profile in terms of dependence, safety and tolerability during long-term use, prolonged-release melatonin has gradually been incorporated into clinical guidelines and expert recommendations in many countries for older adults with chronic insomnia, patients with circadian rhythm disorders and children with neurodevelopmental conditions associated with sleep difficulties, creating a relatively stable base of prescription demand. On the supply side, originator products and a small group of companies with strong modified-release and pediatric-formulation capabilities still enjoy notable barriers to entry in several markets, but as patents and data-exclusivity periods expire, generic competitors are entering, intensifying price competition while also broadening the range of dosage forms and dosing strategies available. Regionally, some European and Commonwealth countries are leveraging prescription and reimbursement channels to drive uptake, North America shows a mix of prescription use and high-standard OTC positioning, and emerging markets are gradually opening as regulatory frameworks become clearer. In summary, pharmaceutical grade melatonin products are likely to sustain growth that outpaces traditional hypnotics but is somewhat more measured than that of the broader melatonin supplement category, functioning primarily as relatively safe, long-term sleep and circadian-management tools within medical channels, clearly differentiated in branding and regulation from ordinary melatonin nutraceuticals.
This report delivers a comprehensive overview of the global Pharmaceutical Grade Melatonin Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Grade Melatonin Products. The Pharmaceutical Grade Melatonin Products market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical Grade Melatonin Products market comprehensively. Regional market sizes by Type, by Application, by Source, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical Grade Melatonin Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pharmaceutical Grade Melatonin Products Market Report

Report Metric Details
Report Name Pharmaceutical Grade Melatonin Products Market
Accounted market size in 2025 US$ 1192 in million
Forecasted market size in 2032 US$ 1865 million
CAGR 6.7%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Tablets
  • Oral Solution
Segment by Source
  • Natural Melatonin
  • Synthetic Melatonin
Segment by Dosage Forms
  • Immediate-Release Tablets
  • Sustained-Release Tablets
by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Natrol, Pharmavite, Nature's Bounty, Jameison, Rexall Sundown, GNC, Church & Dwight, Pfizer, Solgar, Biotics Research, Now Food, Neurim Pharmaceuticals, Slenyto, Nature Made, Centrum, Vitafusion, CVS Health, Leosons Corporation, Zahler, Mauricettes, AGB-Pharma, Alturix, Pharma Nord, Teva, Mylan, Xiu Zheng, By-Health, Conba Pharm, Meiaojian Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Source, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Pharmaceutical Grade Melatonin Products manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Pharmaceutical Grade Melatonin Products sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Grade Melatonin Products Market growing?

Ans: The Pharmaceutical Grade Melatonin Products Market witnessing a CAGR of 6.7% during the forecast period 2026-2032.

What is the Pharmaceutical Grade Melatonin Products Market size in 2032?

Ans: The Pharmaceutical Grade Melatonin Products Market size in 2032 will be US$ 1865 million.

Who are the main players in the Pharmaceutical Grade Melatonin Products Market report?

Ans: The main players in the Pharmaceutical Grade Melatonin Products Market are Natrol, Pharmavite, Nature's Bounty, Jameison, Rexall Sundown, GNC, Church & Dwight, Pfizer, Solgar, Biotics Research, Now Food, Neurim Pharmaceuticals, Slenyto, Nature Made, Centrum, Vitafusion, CVS Health, Leosons Corporation, Zahler, Mauricettes, AGB-Pharma, Alturix, Pharma Nord, Teva, Mylan, Xiu Zheng, By-Health, Conba Pharm, Meiaojian Biotechnology

What are the Application segmentation covered in the Pharmaceutical Grade Melatonin Products Market report?

Ans: The Applications covered in the Pharmaceutical Grade Melatonin Products Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Pharmaceutical Grade Melatonin Products Market report?

Ans: The Types covered in the Pharmaceutical Grade Melatonin Products Market report are Tablets, Oral Solution

1 Pharmaceutical Grade Melatonin Products Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Melatonin Products by Type
1.2.1 Global Pharmaceutical Grade Melatonin Products Market Value by Type: 2025 vs 2032
1.2.2 Tablets
1.2.3 Oral Solution
1.3 Pharmaceutical Grade Melatonin Products by Source
1.3.1 Global Pharmaceutical Grade Melatonin Products Market Value by Source: 2025 vs 2032
1.3.2 Natural Melatonin
1.3.3 Synthetic Melatonin
1.4 Pharmaceutical Grade Melatonin Products by Dosage Forms
1.4.1 Global Pharmaceutical Grade Melatonin Products Market Value by Dosage Forms: 2025 vs 2032
1.4.2 Immediate-Release Tablets
1.4.3 Sustained-Release Tablets
1.5 Pharmaceutical Grade Melatonin Products by Application
1.5.1 Global Pharmaceutical Grade Melatonin Products Market Value by Application: 2025 vs 2032
1.5.2 Hospital and Clinic
1.5.3 Pharmacy
1.5.4 Other
1.6 Global Pharmaceutical Grade Melatonin Products Market Size Estimates and Forecasts
1.6.1 Global Pharmaceutical Grade Melatonin Products Revenue 2021–2032
1.6.2 Global Pharmaceutical Grade Melatonin Products Sales 2021–2032
1.6.3 Global Pharmaceutical Grade Melatonin Products Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Pharmaceutical Grade Melatonin Products Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Melatonin Products Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pharmaceutical Grade Melatonin Products Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pharmaceutical Grade Melatonin Products, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Product Types and Applications
2.7 Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Date of Entry into the Industry
2.8 Global Pharmaceutical Grade Melatonin Products Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Grade Melatonin Products Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pharmaceutical Grade Melatonin Products Players Market Share by Revenue
2.8.3 Global Pharmaceutical Grade Melatonin Products Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Grade Melatonin Products Market Scenario by Region
3.1 Global Pharmaceutical Grade Melatonin Products Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pharmaceutical Grade Melatonin Products Sales by Region: 2021–2032
3.2.1 Global Pharmaceutical Grade Melatonin Products Sales by Region: 2021–2026
3.2.2 Global Pharmaceutical Grade Melatonin Products Sales by Region: 2027–2032
3.3 Global Pharmaceutical Grade Melatonin Products Revenue by Region: 2021–2032
3.3.1 Global Pharmaceutical Grade Melatonin Products Revenue by Region: 2021–2026
3.3.2 Global Pharmaceutical Grade Melatonin Products Revenue by Region: 2027–2032
3.4 North America Pharmaceutical Grade Melatonin Products Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Grade Melatonin Products Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pharmaceutical Grade Melatonin Products Sales by Country (2021–2032)
3.4.3 North America Pharmaceutical Grade Melatonin Products Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Grade Melatonin Products Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Grade Melatonin Products Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pharmaceutical Grade Melatonin Products Sales by Country (2021–2032)
3.5.3 Europe Pharmaceutical Grade Melatonin Products Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Grade Melatonin Products Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Grade Melatonin Products Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pharmaceutical Grade Melatonin Products Sales by Region (2021–2032)
3.6.3 Asia Pacific Pharmaceutical Grade Melatonin Products Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Grade Melatonin Products Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Grade Melatonin Products Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pharmaceutical Grade Melatonin Products Sales by Country (2021–2032)
3.7.3 Latin America Pharmaceutical Grade Melatonin Products Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pharmaceutical Grade Melatonin Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Grade Melatonin Products Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pharmaceutical Grade Melatonin Products Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Grade Melatonin Products Sales by Type (2021–2032)
4.1.1 Global Pharmaceutical Grade Melatonin Products Sales by Type (2021–2026)
4.1.2 Global Pharmaceutical Grade Melatonin Products Sales by Type (2027–2032)
4.1.3 Global Pharmaceutical Grade Melatonin Products Sales Market Share by Type (2021–2032)
4.2 Global Pharmaceutical Grade Melatonin Products Revenue by Type (2021–2032)
4.2.1 Global Pharmaceutical Grade Melatonin Products Revenue by Type (2021–2026)
4.2.2 Global Pharmaceutical Grade Melatonin Products Revenue by Type (2027–2032)
4.2.3 Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Type (2021–2032)
4.3 Global Pharmaceutical Grade Melatonin Products Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pharmaceutical Grade Melatonin Products Sales by Application (2021–2032)
5.1.1 Global Pharmaceutical Grade Melatonin Products Sales by Application (2021–2026)
5.1.2 Global Pharmaceutical Grade Melatonin Products Sales by Application (2027–2032)
5.1.3 Global Pharmaceutical Grade Melatonin Products Sales Market Share by Application (2021–2032)
5.2 Global Pharmaceutical Grade Melatonin Products Revenue by Application (2021–2032)
5.2.1 Global Pharmaceutical Grade Melatonin Products Revenue by Application (2021–2026)
5.2.2 Global Pharmaceutical Grade Melatonin Products Revenue by Application (2027–2032)
5.2.3 Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Application (2021–2032)
5.3 Global Pharmaceutical Grade Melatonin Products Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Natrol
6.1.1 Natrol Company Information
6.1.2 Natrol Description and Business Overview
6.1.3 Natrol Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Natrol Pharmaceutical Grade Melatonin Products Product Portfolio
6.1.5 Natrol Recent Developments/Updates
6.2 Pharmavite
6.2.1 Pharmavite Company Information
6.2.2 Pharmavite Description and Business Overview
6.2.3 Pharmavite Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pharmavite Pharmaceutical Grade Melatonin Products Product Portfolio
6.2.5 Pharmavite Recent Developments/Updates
6.3 Nature's Bounty
6.3.1 Nature's Bounty Company Information
6.3.2 Nature's Bounty Description and Business Overview
6.3.3 Nature's Bounty Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Nature's Bounty Pharmaceutical Grade Melatonin Products Product Portfolio
6.3.5 Nature's Bounty Recent Developments/Updates
6.4 Jameison
6.4.1 Jameison Company Information
6.4.2 Jameison Description and Business Overview
6.4.3 Jameison Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Jameison Pharmaceutical Grade Melatonin Products Product Portfolio
6.4.5 Jameison Recent Developments/Updates
6.5 Rexall Sundown
6.5.1 Rexall Sundown Company Information
6.5.2 Rexall Sundown Description and Business Overview
6.5.3 Rexall Sundown Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Rexall Sundown Pharmaceutical Grade Melatonin Products Product Portfolio
6.5.5 Rexall Sundown Recent Developments/Updates
6.6 GNC
6.6.1 GNC Company Information
6.6.2 GNC Description and Business Overview
6.6.3 GNC Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 GNC Pharmaceutical Grade Melatonin Products Product Portfolio
6.6.5 GNC Recent Developments/Updates
6.7 Church & Dwight
6.7.1 Church & Dwight Company Information
6.7.2 Church & Dwight Description and Business Overview
6.7.3 Church & Dwight Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Church & Dwight Pharmaceutical Grade Melatonin Products Product Portfolio
6.7.5 Church & Dwight Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Pfizer Pharmaceutical Grade Melatonin Products Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Solgar
6.9.1 Solgar Company Information
6.9.2 Solgar Description and Business Overview
6.9.3 Solgar Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Solgar Pharmaceutical Grade Melatonin Products Product Portfolio
6.9.5 Solgar Recent Developments/Updates
6.10 Biotics Research
6.10.1 Biotics Research Company Information
6.10.2 Biotics Research Description and Business Overview
6.10.3 Biotics Research Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Biotics Research Pharmaceutical Grade Melatonin Products Product Portfolio
6.10.5 Biotics Research Recent Developments/Updates
6.11 Now Food
6.11.1 Now Food Company Information
6.11.2 Now Food Description and Business Overview
6.11.3 Now Food Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Now Food Pharmaceutical Grade Melatonin Products Product Portfolio
6.11.5 Now Food Recent Developments/Updates
6.12 Neurim Pharmaceuticals
6.12.1 Neurim Pharmaceuticals Company Information
6.12.2 Neurim Pharmaceuticals Description and Business Overview
6.12.3 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Product Portfolio
6.12.5 Neurim Pharmaceuticals Recent Developments/Updates
6.13 Slenyto
6.13.1 Slenyto Company Information
6.13.2 Slenyto Description and Business Overview
6.13.3 Slenyto Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Slenyto Pharmaceutical Grade Melatonin Products Product Portfolio
6.13.5 Slenyto Recent Developments/Updates
6.14 Nature Made
6.14.1 Nature Made Company Information
6.14.2 Nature Made Description and Business Overview
6.14.3 Nature Made Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Nature Made Pharmaceutical Grade Melatonin Products Product Portfolio
6.14.5 Nature Made Recent Developments/Updates
6.15 Centrum
6.15.1 Centrum Company Information
6.15.2 Centrum Description and Business Overview
6.15.3 Centrum Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Centrum Pharmaceutical Grade Melatonin Products Product Portfolio
6.15.5 Centrum Recent Developments/Updates
6.16 Vitafusion
6.16.1 Vitafusion Company Information
6.16.2 Vitafusion Description and Business Overview
6.16.3 Vitafusion Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Vitafusion Pharmaceutical Grade Melatonin Products Product Portfolio
6.16.5 Vitafusion Recent Developments/Updates
6.17 CVS Health
6.17.1 CVS Health Company Information
6.17.2 CVS Health Description and Business Overview
6.17.3 CVS Health Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 CVS Health Pharmaceutical Grade Melatonin Products Product Portfolio
6.17.5 CVS Health Recent Developments/Updates
6.18 Leosons Corporation
6.18.1 Leosons Corporation Company Information
6.18.2 Leosons Corporation Description and Business Overview
6.18.3 Leosons Corporation Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Leosons Corporation Pharmaceutical Grade Melatonin Products Product Portfolio
6.18.5 Leosons Corporation Recent Developments/Updates
6.19 Zahler
6.19.1 Zahler Company Information
6.19.2 Zahler Description and Business Overview
6.19.3 Zahler Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Zahler Pharmaceutical Grade Melatonin Products Product Portfolio
6.19.5 Zahler Recent Developments/Updates
6.20 Mauricettes
6.20.1 Mauricettes Company Information
6.20.2 Mauricettes Description and Business Overview
6.20.3 Mauricettes Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Mauricettes Pharmaceutical Grade Melatonin Products Product Portfolio
6.20.5 Mauricettes Recent Developments/Updates
6.21 AGB-Pharma
6.21.1 AGB-Pharma Company Information
6.21.2 AGB-Pharma Description and Business Overview
6.21.3 AGB-Pharma Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 AGB-Pharma Pharmaceutical Grade Melatonin Products Product Portfolio
6.21.5 AGB-Pharma Recent Developments/Updates
6.22 Alturix
6.22.1 Alturix Company Information
6.22.2 Alturix Description and Business Overview
6.22.3 Alturix Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Alturix Pharmaceutical Grade Melatonin Products Product Portfolio
6.22.5 Alturix Recent Developments/Updates
6.23 Pharma Nord
6.23.1 Pharma Nord Company Information
6.23.2 Pharma Nord Description and Business Overview
6.23.3 Pharma Nord Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Pharma Nord Pharmaceutical Grade Melatonin Products Product Portfolio
6.23.5 Pharma Nord Recent Developments/Updates
6.24 Teva
6.24.1 Teva Company Information
6.24.2 Teva Description and Business Overview
6.24.3 Teva Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Teva Pharmaceutical Grade Melatonin Products Product Portfolio
6.24.5 Teva Recent Developments/Updates
6.25 Mylan
6.25.1 Mylan Company Information
6.25.2 Mylan Description and Business Overview
6.25.3 Mylan Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Mylan Pharmaceutical Grade Melatonin Products Product Portfolio
6.25.5 Mylan Recent Developments/Updates
6.26 Xiu Zheng
6.26.1 Xiu Zheng Company Information
6.26.2 Xiu Zheng Description and Business Overview
6.26.3 Xiu Zheng Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Xiu Zheng Pharmaceutical Grade Melatonin Products Product Portfolio
6.26.5 Xiu Zheng Recent Developments/Updates
6.27 By-Health
6.27.1 By-Health Company Information
6.27.2 By-Health Description and Business Overview
6.27.3 By-Health Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 By-Health Pharmaceutical Grade Melatonin Products Product Portfolio
6.27.5 By-Health Recent Developments/Updates
6.28 Conba Pharm
6.28.1 Conba Pharm Company Information
6.28.2 Conba Pharm Description and Business Overview
6.28.3 Conba Pharm Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 Conba Pharm Pharmaceutical Grade Melatonin Products Product Portfolio
6.28.5 Conba Pharm Recent Developments/Updates
6.29 Meiaojian Biotechnology
6.29.1 Meiaojian Biotechnology Company Information
6.29.2 Meiaojian Biotechnology Description and Business Overview
6.29.3 Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Product Portfolio
6.29.5 Meiaojian Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Grade Melatonin Products Industry Chain Analysis
7.2 Pharmaceutical Grade Melatonin Products Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Grade Melatonin Products Production Mode & Process Analysis
7.4 Pharmaceutical Grade Melatonin Products Sales and Marketing
7.4.1 Pharmaceutical Grade Melatonin Products Sales Channels
7.4.2 Pharmaceutical Grade Melatonin Products Distributors
7.5 Pharmaceutical Grade Melatonin Products Customer Analysis
8 Pharmaceutical Grade Melatonin Products Market Dynamics
8.1 Pharmaceutical Grade Melatonin Products Industry Trends
8.2 Pharmaceutical Grade Melatonin Products Market Drivers
8.3 Pharmaceutical Grade Melatonin Products Market Challenges
8.4 Pharmaceutical Grade Melatonin Products Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pharmaceutical Grade Melatonin Products Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Pharmaceutical Grade Melatonin Products Market Value by Source (US$ Million), 2025 vs 2032
 Table 3. Global Pharmaceutical Grade Melatonin Products Market Value by Dosage Forms (US$ Million), 2025 vs 2032
 Table 4. Global Pharmaceutical Grade Melatonin Products Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Pharmaceutical Grade Melatonin Products Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Pharmaceutical Grade Melatonin Products Sales (K Units) of Key Manufacturers (2021–2026)
 Table 7. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Pharmaceutical Grade Melatonin Products Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Pharmaceutical Grade Melatonin Products Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Pharmaceutical Grade Melatonin Products, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Product Types and Applications
 Table 14. Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Pharmaceutical Grade Melatonin Products Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical Grade Melatonin Products Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Pharmaceutical Grade Melatonin Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Pharmaceutical Grade Melatonin Products Sales by Region (K Units), 2021–2026
 Table 20. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Region (2021–2026)
 Table 21. Global Pharmaceutical Grade Melatonin Products Sales by Region (K Units), 2027–2032
 Table 22. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Region (2027–2032)
 Table 23. Global Pharmaceutical Grade Melatonin Products Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Region (2021–2026)
 Table 25. Global Pharmaceutical Grade Melatonin Products Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Region (2027–2032)
 Table 27. North America Pharmaceutical Grade Melatonin Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2021–2026
 Table 29. North America Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2027–2032
 Table 30. North America Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Pharmaceutical Grade Melatonin Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2021–2026
 Table 34. Europe Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2027–2032
 Table 35. Europe Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Pharmaceutical Grade Melatonin Products Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Pharmaceutical Grade Melatonin Products Sales by Region (K Units), 2021–2026
 Table 39. Asia Pacific Pharmaceutical Grade Melatonin Products Sales by Region (K Units), 2027–2032
 Table 40. Asia Pacific Pharmaceutical Grade Melatonin Products Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Pharmaceutical Grade Melatonin Products Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Pharmaceutical Grade Melatonin Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2021–2026
 Table 44. Latin America Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2027–2032
 Table 45. Latin America Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2021–2026
 Table 49. Middle East and Africa Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2027–2032
 Table 50. Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Pharmaceutical Grade Melatonin Products Sales (K Units) by Type (2021–2026)
 Table 53. Global Pharmaceutical Grade Melatonin Products Sales (K Units) by Type (2027–2032)
 Table 54. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Type (2021–2026)
 Table 55. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Type (2027–2032)
 Table 56. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Type (2021–2026)
 Table 59. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Type (2027–2032)
 Table 60. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Type (2021–2026)
 Table 61. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Type (2027–2032)
 Table 62. Global Pharmaceutical Grade Melatonin Products Sales (K Units) by Application (2021–2026)
 Table 63. Global Pharmaceutical Grade Melatonin Products Sales (K Units) by Application (2027–2032)
 Table 64. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Application (2021–2026)
 Table 65. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Application (2027–2032)
 Table 66. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Application (2021–2026)
 Table 69. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Application (2027–2032)
 Table 70. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Application (2021–2026)
 Table 71. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Application (2027–2032)
 Table 72. Natrol Company Information
 Table 73. Natrol Description and Business Overview
 Table 74. Natrol Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 75. Natrol Pharmaceutical Grade Melatonin Products Product
 Table 76. Natrol Recent Developments/Updates
 Table 77. Pharmavite Company Information
 Table 78. Pharmavite Description and Business Overview
 Table 79. Pharmavite Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 80. Pharmavite Pharmaceutical Grade Melatonin Products Product
 Table 81. Pharmavite Recent Developments/Updates
 Table 82. Nature's Bounty Company Information
 Table 83. Nature's Bounty Description and Business Overview
 Table 84. Nature's Bounty Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 85. Nature's Bounty Pharmaceutical Grade Melatonin Products Product
 Table 86. Nature's Bounty Recent Developments/Updates
 Table 87. Jameison Company Information
 Table 88. Jameison Description and Business Overview
 Table 89. Jameison Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 90. Jameison Pharmaceutical Grade Melatonin Products Product
 Table 91. Jameison Recent Developments/Updates
 Table 92. Rexall Sundown Company Information
 Table 93. Rexall Sundown Description and Business Overview
 Table 94. Rexall Sundown Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 95. Rexall Sundown Pharmaceutical Grade Melatonin Products Product
 Table 96. Rexall Sundown Recent Developments/Updates
 Table 97. GNC Company Information
 Table 98. GNC Description and Business Overview
 Table 99. GNC Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 100. GNC Pharmaceutical Grade Melatonin Products Product
 Table 101. GNC Recent Developments/Updates
 Table 102. Church & Dwight Company Information
 Table 103. Church & Dwight Description and Business Overview
 Table 104. Church & Dwight Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 105. Church & Dwight Pharmaceutical Grade Melatonin Products Product
 Table 106. Church & Dwight Recent Developments/Updates
 Table 107. Pfizer Company Information
 Table 108. Pfizer Description and Business Overview
 Table 109. Pfizer Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 110. Pfizer Pharmaceutical Grade Melatonin Products Product
 Table 111. Pfizer Recent Developments/Updates
 Table 112. Solgar Company Information
 Table 113. Solgar Description and Business Overview
 Table 114. Solgar Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 115. Solgar Pharmaceutical Grade Melatonin Products Product
 Table 116. Solgar Recent Developments/Updates
 Table 117. Biotics Research Company Information
 Table 118. Biotics Research Description and Business Overview
 Table 119. Biotics Research Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 120. Biotics Research Pharmaceutical Grade Melatonin Products Product
 Table 121. Biotics Research Recent Developments/Updates
 Table 122. Now Food Company Information
 Table 123. Now Food Description and Business Overview
 Table 124. Now Food Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 125. Now Food Pharmaceutical Grade Melatonin Products Product
 Table 126. Now Food Recent Developments/Updates
 Table 127. Neurim Pharmaceuticals Company Information
 Table 128. Neurim Pharmaceuticals Description and Business Overview
 Table 129. Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 130. Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Product
 Table 131. Neurim Pharmaceuticals Recent Developments/Updates
 Table 132. Slenyto Company Information
 Table 133. Slenyto Description and Business Overview
 Table 134. Slenyto Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 135. Slenyto Pharmaceutical Grade Melatonin Products Product
 Table 136. Slenyto Recent Developments/Updates
 Table 137. Nature Made Company Information
 Table 138. Nature Made Description and Business Overview
 Table 139. Nature Made Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 140. Nature Made Pharmaceutical Grade Melatonin Products Product
 Table 141. Nature Made Recent Developments/Updates
 Table 142. Centrum Company Information
 Table 143. Centrum Description and Business Overview
 Table 144. Centrum Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 145. Centrum Pharmaceutical Grade Melatonin Products Product
 Table 146. Centrum Recent Developments/Updates
 Table 147. Vitafusion Company Information
 Table 148. Vitafusion Description and Business Overview
 Table 149. Vitafusion Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 150. Vitafusion Pharmaceutical Grade Melatonin Products Product
 Table 151. Vitafusion Recent Developments/Updates
 Table 152. CVS Health Company Information
 Table 153. CVS Health Description and Business Overview
 Table 154. CVS Health Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 155. CVS Health Pharmaceutical Grade Melatonin Products Product
 Table 156. CVS Health Recent Developments/Updates
 Table 157. Leosons Corporation Company Information
 Table 158. Leosons Corporation Description and Business Overview
 Table 159. Leosons Corporation Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 160. Leosons Corporation Pharmaceutical Grade Melatonin Products Product
 Table 161. Leosons Corporation Recent Developments/Updates
 Table 162. Zahler Company Information
 Table 163. Zahler Description and Business Overview
 Table 164. Zahler Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 165. Zahler Pharmaceutical Grade Melatonin Products Product
 Table 166. Zahler Recent Developments/Updates
 Table 167. Mauricettes Company Information
 Table 168. Mauricettes Description and Business Overview
 Table 169. Mauricettes Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 170. Mauricettes Pharmaceutical Grade Melatonin Products Product
 Table 171. Mauricettes Recent Developments/Updates
 Table 172. AGB-Pharma Company Information
 Table 173. AGB-Pharma Description and Business Overview
 Table 174. AGB-Pharma Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 175. AGB-Pharma Pharmaceutical Grade Melatonin Products Product
 Table 176. AGB-Pharma Recent Developments/Updates
 Table 177. Alturix Company Information
 Table 178. Alturix Description and Business Overview
 Table 179. Alturix Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 180. Alturix Pharmaceutical Grade Melatonin Products Product
 Table 181. Alturix Recent Developments/Updates
 Table 182. Pharma Nord Company Information
 Table 183. Pharma Nord Description and Business Overview
 Table 184. Pharma Nord Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 185. Pharma Nord Pharmaceutical Grade Melatonin Products Product
 Table 186. Pharma Nord Recent Developments/Updates
 Table 187. Teva Company Information
 Table 188. Teva Description and Business Overview
 Table 189. Teva Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 190. Teva Pharmaceutical Grade Melatonin Products Product
 Table 191. Teva Recent Developments/Updates
 Table 192. Mylan Company Information
 Table 193. Mylan Description and Business Overview
 Table 194. Mylan Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 195. Mylan Pharmaceutical Grade Melatonin Products Product
 Table 196. Mylan Recent Developments/Updates
 Table 197. Xiu Zheng Company Information
 Table 198. Xiu Zheng Description and Business Overview
 Table 199. Xiu Zheng Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 200. Xiu Zheng Pharmaceutical Grade Melatonin Products Product
 Table 201. Xiu Zheng Recent Developments/Updates
 Table 202. By-Health Company Information
 Table 203. By-Health Description and Business Overview
 Table 204. By-Health Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 205. By-Health Pharmaceutical Grade Melatonin Products Product
 Table 206. By-Health Recent Developments/Updates
 Table 207. Conba Pharm Company Information
 Table 208. Conba Pharm Description and Business Overview
 Table 209. Conba Pharm Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 210. Conba Pharm Pharmaceutical Grade Melatonin Products Product
 Table 211. Conba Pharm Recent Developments/Updates
 Table 212. Meiaojian Biotechnology Company Information
 Table 213. Meiaojian Biotechnology Description and Business Overview
 Table 214. Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 215. Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Product
 Table 216. Meiaojian Biotechnology Recent Developments/Updates
 Table 217. Key Raw Materials Lists
 Table 218. Raw Materials Key Suppliers Lists
 Table 219. Pharmaceutical Grade Melatonin Products Distributors List
 Table 220. Pharmaceutical Grade Melatonin Products Customers List
 Table 221. Pharmaceutical Grade Melatonin Products Market Trends
 Table 222. Pharmaceutical Grade Melatonin Products Market Drivers
 Table 223. Pharmaceutical Grade Melatonin Products Market Challenges
 Table 224. Pharmaceutical Grade Melatonin Products Market Restraints
 Table 225. Research Programs/Design for This Report
 Table 226. Key Data Information from Secondary Sources
 Table 227. Key Data Information from Primary Sources
 Table 228. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharmaceutical Grade Melatonin Products
 Figure 2. Global Pharmaceutical Grade Melatonin Products Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Pharmaceutical Grade Melatonin Products Market Share by Type: 2025 & 2032
 Figure 4. Tablets Product Picture
 Figure 5. Oral Solution Product Picture
 Figure 6. Global Pharmaceutical Grade Melatonin Products Market Value by Source (US$ Million), 2021–2032
 Figure 7. Global Pharmaceutical Grade Melatonin Products Market Share by Source: 2025 vs 2032
 Figure 8. Natural Melatonin Product Picture
 Figure 9. Synthetic Melatonin Product Picture
 Figure 10. Global Pharmaceutical Grade Melatonin Products Market Value by Dosage Forms (US$ Million), 2021–2032
 Figure 11. Global Pharmaceutical Grade Melatonin Products Market Share by Dosage Forms: 2025 vs 2032
 Figure 12. Immediate-Release Tablets Product Picture
 Figure 13. Sustained-Release Tablets Product Picture
 Figure 14. Global Pharmaceutical Grade Melatonin Products Market Value by Application (US$ Million), 2021–2032
 Figure 15. Global Pharmaceutical Grade Melatonin Products Market Share by Application: 2025 & 2032
 Figure 16. Hospital and Clinic
 Figure 17. Pharmacy
 Figure 18. Other
 Figure 19. Global Pharmaceutical Grade Melatonin Products Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Pharmaceutical Grade Melatonin Products Market Size (US$ Million), 2021–2032
 Figure 21. Global Pharmaceutical Grade Melatonin Products Sales (K Units), 2021–2032
 Figure 22. Global Pharmaceutical Grade Melatonin Products Average Price (US$/Unit), 2021–2032
 Figure 23. Pharmaceutical Grade Melatonin Products Report Years Considered
 Figure 24. Pharmaceutical Grade Melatonin Products Sales Share by Manufacturers in 2025
 Figure 25. Global Pharmaceutical Grade Melatonin Products Revenue Share by Manufacturers in 2025
 Figure 26. Top 5 and Top 10 Global Pharmaceutical Grade Melatonin Products Players: Market Share by Revenue in Pharmaceutical Grade Melatonin Products in 2025
 Figure 27. Pharmaceutical Grade Melatonin Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 28. Global Pharmaceutical Grade Melatonin Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 29. North America Pharmaceutical Grade Melatonin Products Sales Market Share by Country (2021–2032)
 Figure 30. North America Pharmaceutical Grade Melatonin Products Revenue Market Share by Country (2021–2032)
 Figure 31. United States Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Canada Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Europe Pharmaceutical Grade Melatonin Products Sales Market Share by Country (2021–2032)
 Figure 34. Europe Pharmaceutical Grade Melatonin Products Revenue Market Share by Country (2021–2032)
 Figure 35. Germany Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. France Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. U.K. Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Italy Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Russia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Asia Pacific Pharmaceutical Grade Melatonin Products Sales Market Share by Region (2021–2032)
 Figure 41. Asia Pacific Pharmaceutical Grade Melatonin Products Revenue Market Share by Region (2021–2032)
 Figure 42. China Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Japan Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. South Korea Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. India Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Australia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. China Taiwan Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Southeast Asia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Latin America Pharmaceutical Grade Melatonin Products Sales Market Share by Country (2021–2032)
 Figure 50. Latin America Pharmaceutical Grade Melatonin Products Revenue Market Share by Country (2021–2032)
 Figure 51. Mexico Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Brazil Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Argentina Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Colombia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Middle East and Africa Pharmaceutical Grade Melatonin Products Sales Market Share by Country (2021–2032)
 Figure 56. Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue Market Share by Country (2021–2032)
 Figure 57. Turkey Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Saudi Arabia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. UAE Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Global Sales Market Share of Pharmaceutical Grade Melatonin Products by Type (2021–2032)
 Figure 61. Global Revenue Market Share of Pharmaceutical Grade Melatonin Products by Type (2021–2032)
 Figure 62. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Type (2021–2032)
 Figure 63. Global Sales Market Share of Pharmaceutical Grade Melatonin Products by Application (2021–2032)
 Figure 64. Global Revenue Market Share of Pharmaceutical Grade Melatonin Products by Application (2021–2032)
 Figure 65. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Application (2021–2032)
 Figure 66. Pharmaceutical Grade Melatonin Products Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network